Medartis Holding AG is a Switzerland-based medical technology firm, founded in 1997 and headquartered in Basel. The company specializes in the global creation, production, and distribution of advanced implant solutions. These sophisticated medical devices are engineered to support the surgical repair and stabilization of bone fractures, specifically targeting injuries in both upper and lower limbs, as well as intricate cranio-maxillofacial surgeries. Operating under its prominent APTUS and MODUS brands, Medartis provides a comprehensive array of osteosynthesis instruments. These specialized tools and implants are designed for a wide spectrum of anatomical applications, including procedures involving the hand, wrist, elbow, shoulder, foot, and ankle, alongside the mandible, midface, orthognathic, and cranial regions. Medartis serves a diverse international client base, including surgeons, hospitals, medical centers, and various group purchasing organizations.
The current price of MDRSF is $115.00 USD — it has increased by +15.05% in the past 24 hours. Watch Medartis stock price performance more closely on the chart.
What is Medartis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medartis stocks are traded under the ticker MDRSF.
What is Medartis market cap?▼
Today Medartis has the market capitalization of 1.57B
When is the next Medartis earnings date?▼
Medartis is going to release the next earnings report on August 18, 2026.
What is Medartis revenue for the last year?▼
Medartis revenue for the last year amounts to 496.67M USD.
What is Medartis net income for the last year?▼
MDRSF net income for the last year is 7.8M USD.
How many employees does Medartis have?▼
As of June 20, 2026, the company has 816 employees.
In which sector is Medartis located?▼
Medartis operates in the Health & Wellness sector.
When did Medartis complete a stock split?▼
The last stock split for Medartis was on June 01, 2018 with a ratio of 1:10.
Where is Medartis headquartered?▼
Medartis is headquartered in Basel, United States.